Baidu
map

JAMA Oncol:子宫肌瘤切除术后潜在的癌症

2015-02-23 赵洲 MedSci原创

子宫肌瘤是子宫中的良性平滑肌瘤。这些肌瘤是很常见的,据估计20%-50%女性有子宫肌瘤。尽管子宫肌瘤通过是无症状的,但能造成疼痛、月经不调以及生育能力降低。子宫肌瘤切除术现在常常通过微创手术得以实现。电动分碎术,或者使用机械装置切除子宫肌瘤有可能被用于促进子宫肌瘤的切除。为了分析潜在的癌症和癌症前期变化的患病率,研究人员使用了美国国家数据库进行回顾性分析。数据是在2006年1月至2



子宫肌瘤是子宫中的良性平滑肌瘤。这些肌瘤是很常见的,据估计20%-50%女性有子宫肌瘤。尽管子宫肌瘤通过是无症状的,但能造成疼痛、月经不调以及生育能力降低。子宫肌瘤切除术现在常常通过微创手术得以实现。电动分碎术,或者使用机械装置切除子宫肌瘤有可能被用于促进子宫肌瘤的切除。为了分析潜在的癌症和癌症前期变化的患病率,研究人员使用了美国国家数据库进行回顾性分析。数据是在2006年1月至2012年12月间,496所医院中有子宫肌瘤女性所提供的。在当时,电动分碎术已经被研究了。对子宫癌、不确定性恶性肿瘤和子宫内膜增生的患病率进行估计。建立多变量的混合影响回归模型以检验电动分碎术使用的影响因素和与不良病理结果相关的因素。

本次试验共有样本数41777例,其中3220人(7.7%)接受电动分碎术切除子宫肌瘤。在不使用电动分碎术切除子宫肌瘤的患者中,有73人(0.19%,95%CI 0.15%-0.23%)罹患子宫癌;使用电动分碎术切除子宫肌瘤的患者中,有3人(0.09%,95%CI 0.02%-0.27%)罹患子宫癌。不确定性恶性肿瘤和子宫内膜增生相应的比例分别为0.67%(257人)和0.43%(14人)。子宫癌最严重的风险因素是高龄。

总言之,无论是否使用电动分碎术切除子宫肌瘤,癌症的患病率和癌症前期的子宫异常比例都是较低的。但是,研究表明随着年龄增加,风险相应地增大。因此,对高龄子宫肌妇女使用电动分碎术应当更为审慎。

原始出处:

Wright JD, Tergas AI, Cui R, et al. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy. JAMA Oncol.Published online February 19, 2015. doi:10.1001/jamaoncol.2014.206.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1864608, encodeId=bb8418646087d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Aug 13 14:00:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876701, encodeId=342518e6701a1, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Oct 31 16:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23701, encodeId=d17d23e01ed, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668444, encodeId=3e3f16684440d, content=<a href='/topic/show?id=655445190a7' target=_blank style='color:#2F92EE;'>#子宫肌瘤切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45190, encryptionId=655445190a7, topicName=子宫肌瘤切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3826305128, createdName=bnurmamat, createdTime=Mon Oct 26 17:00:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17157, encodeId=5fb11e15750, content=好文章,超赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Fri Feb 27 23:09:00 CST 2015, time=2015-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16921, encodeId=0cf716921bb, content=感谢你们的辛勤付出, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:20:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16851, encodeId=d75e1685129, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Tue Feb 24 11:12:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-08-13 minlingfeng
  2. [GetPortalCommentsPageByObjectIdResponse(id=1864608, encodeId=bb8418646087d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Aug 13 14:00:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876701, encodeId=342518e6701a1, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Oct 31 16:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23701, encodeId=d17d23e01ed, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668444, encodeId=3e3f16684440d, content=<a href='/topic/show?id=655445190a7' target=_blank style='color:#2F92EE;'>#子宫肌瘤切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45190, encryptionId=655445190a7, topicName=子宫肌瘤切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3826305128, createdName=bnurmamat, createdTime=Mon Oct 26 17:00:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17157, encodeId=5fb11e15750, content=好文章,超赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Fri Feb 27 23:09:00 CST 2015, time=2015-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16921, encodeId=0cf716921bb, content=感谢你们的辛勤付出, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:20:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16851, encodeId=d75e1685129, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Tue Feb 24 11:12:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1864608, encodeId=bb8418646087d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Aug 13 14:00:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876701, encodeId=342518e6701a1, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Oct 31 16:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23701, encodeId=d17d23e01ed, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668444, encodeId=3e3f16684440d, content=<a href='/topic/show?id=655445190a7' target=_blank style='color:#2F92EE;'>#子宫肌瘤切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45190, encryptionId=655445190a7, topicName=子宫肌瘤切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3826305128, createdName=bnurmamat, createdTime=Mon Oct 26 17:00:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17157, encodeId=5fb11e15750, content=好文章,超赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Fri Feb 27 23:09:00 CST 2015, time=2015-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16921, encodeId=0cf716921bb, content=感谢你们的辛勤付出, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:20:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16851, encodeId=d75e1685129, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Tue Feb 24 11:12:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-05-16 ljjj1053

    很不错学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1864608, encodeId=bb8418646087d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Aug 13 14:00:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876701, encodeId=342518e6701a1, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Oct 31 16:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23701, encodeId=d17d23e01ed, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668444, encodeId=3e3f16684440d, content=<a href='/topic/show?id=655445190a7' target=_blank style='color:#2F92EE;'>#子宫肌瘤切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45190, encryptionId=655445190a7, topicName=子宫肌瘤切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3826305128, createdName=bnurmamat, createdTime=Mon Oct 26 17:00:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17157, encodeId=5fb11e15750, content=好文章,超赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Fri Feb 27 23:09:00 CST 2015, time=2015-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16921, encodeId=0cf716921bb, content=感谢你们的辛勤付出, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:20:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16851, encodeId=d75e1685129, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Tue Feb 24 11:12:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1864608, encodeId=bb8418646087d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Aug 13 14:00:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876701, encodeId=342518e6701a1, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Oct 31 16:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23701, encodeId=d17d23e01ed, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668444, encodeId=3e3f16684440d, content=<a href='/topic/show?id=655445190a7' target=_blank style='color:#2F92EE;'>#子宫肌瘤切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45190, encryptionId=655445190a7, topicName=子宫肌瘤切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3826305128, createdName=bnurmamat, createdTime=Mon Oct 26 17:00:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17157, encodeId=5fb11e15750, content=好文章,超赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Fri Feb 27 23:09:00 CST 2015, time=2015-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16921, encodeId=0cf716921bb, content=感谢你们的辛勤付出, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:20:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16851, encodeId=d75e1685129, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Tue Feb 24 11:12:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-02-27 xiaoai5777

    好文章,超赞

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1864608, encodeId=bb8418646087d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Aug 13 14:00:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876701, encodeId=342518e6701a1, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Oct 31 16:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23701, encodeId=d17d23e01ed, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668444, encodeId=3e3f16684440d, content=<a href='/topic/show?id=655445190a7' target=_blank style='color:#2F92EE;'>#子宫肌瘤切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45190, encryptionId=655445190a7, topicName=子宫肌瘤切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3826305128, createdName=bnurmamat, createdTime=Mon Oct 26 17:00:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17157, encodeId=5fb11e15750, content=好文章,超赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Fri Feb 27 23:09:00 CST 2015, time=2015-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16921, encodeId=0cf716921bb, content=感谢你们的辛勤付出, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:20:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16851, encodeId=d75e1685129, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Tue Feb 24 11:12:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-02-24 zhouanxiu

    感谢你们的辛勤付出

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1864608, encodeId=bb8418646087d, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Thu Aug 13 14:00:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876701, encodeId=342518e6701a1, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Oct 31 16:00:00 CST 2015, time=2015-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23701, encodeId=d17d23e01ed, content=很不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=194, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Sat May 16 19:31:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668444, encodeId=3e3f16684440d, content=<a href='/topic/show?id=655445190a7' target=_blank style='color:#2F92EE;'>#子宫肌瘤切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45190, encryptionId=655445190a7, topicName=子宫肌瘤切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d3826305128, createdName=bnurmamat, createdTime=Mon Oct 26 17:00:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17157, encodeId=5fb11e15750, content=好文章,超赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36a81612921, createdName=xiaoai5777, createdTime=Fri Feb 27 23:09:00 CST 2015, time=2015-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16921, encodeId=0cf716921bb, content=感谢你们的辛勤付出, beContent=null, objectType=article, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3yz0JbjHQ7nicJU7lHMOu0Itf3Zv3VBzEvK3k4AFPBXhiaxIRNGVI33GicoRXQEjkaasjdlWKwZuwcyhDP9Jibqt5ct/0, createdBy=f1281613275, createdName=zhouanxiu, createdTime=Tue Feb 24 15:20:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16851, encodeId=d75e1685129, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Tue Feb 24 11:12:00 CST 2015, time=2015-02-24, status=1, ipAttribution=)]
    2015-02-24 orthoW

    不错的文章,学习了

    0

相关资讯

AJHG:GWAS方法鉴定出子宫肌瘤相关的遗传突变FAS基因

    子宫肌瘤是妇女常见的一种骨盆肿瘤,其在美国是妇女子宫切除的主要原因之一,来自布莱根妇女医院的研究者利用全基因组方法,首次发现了白人妇女子宫肌瘤的遗传风险等位基因,相关研究发现于10月4日刊登在了国际杂志The American Journal of Human Genetics上,这项研究或为子宫肌瘤的疗法提供思路和帮助。    

朱兰教授:子宫肌瘤的非手术治疗

朱兰:北京协和医院妇产科副 主任,教授,博士研究生导 师,中华医学会妇产科分会盆 底学组副组长兼秘书  药物治疗   雄激素   多用于围绝经期治疗,患者月经量多,经子宫内膜病理检查除外恶性变后,临床上常用甲基睾丸素5 mg,1次/d或2次/d,每月用量< 250 mg,以免男性化。该治疗方案没有太多研究和文献更新。   米非司酮   为孕激素受体拮抗剂,具有抗孕激素和抗糖皮质激素

Biol Reprod:维生素D能抑制子宫肌瘤生长

由美国国立卫生研究院资助的一项研究表明:维生素D减少老鼠良性子宫肌瘤的大小。 子宫肌瘤是育龄妇女最常见的非癌性肿瘤。肌瘤主要生长在子宫壁内和周围。百分之三十的25至44岁女性年龄有肌瘤相关症状如腰痛、严重的阴道出血或月经周期疼痛。子宫肌瘤会导致不孕、流产或早产等怀孕并发症。手术切除子宫后,还有一些妇女会罹患子宫肌瘤相关症状,每年约20万美国妇女需要接受手术治疗。 美国黑人妇女罹患肌瘤的

NEJM:了解肿瘤背后的祸首

子宫肌瘤是最常见的一种女性肿瘤,近年来在了解这类肿瘤的起始和生长机制方面取得了巨大的进展。发表在10月3日《新英格兰医学》(NEJM)杂志上的一篇新论文,综述了有关孕酮、干细胞和肿瘤突变在子宫肌瘤中所起作用的最新研究进展,为研究和药物开发指出了新方向。 论文的作者、美国西北大学Feinberg医学院及西北纪念医院妇产科学教授Serdar Bulun博士说:“这些研究发现代表了我们探讨新治疗的思维

Baidu
map
Baidu
map
Baidu
map